MTMR6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.85120000000861E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.27570000000444E-05 |
Normal-vs-Stage2 |
1.389210E-01 |
Normal-vs-Stage3 |
3.317900E-02 |
Normal-vs-Stage4 |
9.180100E-04 |
Stage1-vs-Stage2 |
3.468400E-01 |
Stage1-vs-Stage3 |
5.358400E-01 |
Stage1-vs-Stage4 |
4.748600E-01 |
Stage2-vs-Stage3 |
7.354400E-01 |
Stage2-vs-Stage4 |
1.968570E-01 |
Stage3-vs-Stage4 |
2.832400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.90131999999732E-05 |
Normal-vs-AfricanAmerican |
3.715600E-02 |
Normal-vs-Asian |
3.356200E-02 |
Caucasian-vs-AfricanAmerican |
9.486200E-02 |
Caucasian-vs-Asian |
8.349600E-01 |
AfricanAmerican-vs-Asian |
4.876000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.91320000000983E-06 |
Normal-vs-Female |
1.401240E-01 |
Male-vs-Female |
1.053920E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.456350E-03 |
Normal-vs-Extreme_Weight |
2.03539999998892E-06 |
Normal-vs-Obese |
1.201550E-02 |
Normal-vs-Extreme_Obese |
6.415600E-03 |
Normal_Weight-vs-Extreme_Weight |
5.814800E-01 |
Normal_Weight-vs-Obese |
2.327400E-01 |
Normal_Weight-vs-Extreme_Obese |
9.279600E-01 |
Extreme_Weight-vs-Obese |
3.018400E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.163800E-01 |
Obese-vs-Extreme_Obese |
3.822400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.820300E-02 |
Normal-vs-Age(41-60Yrs) |
1.237870E-02 |
Normal-vs-Age(61-80Yrs) |
2.76789999997806E-06 |
Normal-vs-Age(81-100Yrs) |
9.808499999997E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.950400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.792000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.934000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.379900E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.543900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.16549999999538E-05 |
Normal-VS-Type2 PRCC |
8.080200E-03 |
Normal-VS-KIRP CIMP |
4.26900000000119E-05 |
Normal-VS-Unclassified PRCC |
2.864600E-01 |
Type1 PRCC-VS-Type2 PRCC |
3.454600E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.996300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
8.910100E-02 |
Type2 PRCC-VS-KIRP CIMP |
1.154020E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.399000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.040900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.181950E-03 |
Normal-vs-N1 |
4.695100E-03 |
Normal-vs-N2 |
3.567500E-04 |
N0-vs-N1 |
9.666000E-01 |
N0-vs-N2 |
2.092800E-01 |
N1-vs-N2 |
1.600570E-01 |
|
|